AI Article Synopsis
- Interest in circulating cell free DNA (ccfDNA) has surged, particularly for its potential application in cancer management, as blood levels of ccfDNA correlate with various diseases.
- Unlike traditional tissue biopsies, measuring ccfDNA is a non-invasive method for cancer detection and offers benefits in monitoring disease progression and predicting patient prognosis.
- Advances in quantitative detection techniques are being developed to enhance sensitivity, addressing the challenge of ccfDNA's low concentration in blood samples.
Article Abstract
The interest in the potential application value of circulating cell free DNA (ccfDNA) has increased rapidly in recent years, as numerous researchers have demonstrated that the change of its level in the blood is associated with many diseases. Its potential role in cancer management is of particular concern. In comparison with traditional invasive tissue biopsy, quantitative analysis of ccfDNA level for the detection of cancer is advantageous due to the non-invasiveness of blood collection. Moreover, its clinical significance in prognosis prediction and dynamic monitoring of disease progression in cancer patients is equally worthy of attention. At the same time, quantitative detection of ccfDNA is being improved to pursue higher sensitivity due to its low concentration in the blood sample. In this review, we will summarize the progress in quantitative technology of ccfDNA and describe the possible relationship between ccfDNA level and cancer diagnosis and prognosis prediction.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.cancergen.2019.10.001 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!